November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Steven Treon on Promising Advances: 3 Novel Therapies Transforming Waldenström’s Macroglobulinemia
Jul 19, 2025, 19:00

Steven Treon on Promising Advances: 3 Novel Therapies Transforming Waldenström’s Macroglobulinemia

The Video Journal of Hematology and Hematological Oncology shared a post on X:

”What are some of the most exciting developments in the field of Waldenström’s macroglobulinemia? We caught up with Steven Treon of Dana-Farber Cancer Institute at 18 ICML to find out!”

Watch the interview here.

Dr. Steven Treon highlights promising advances in Waldenström’s macroglobulinemia, focusing on novel therapies like BTK degraders, that demonstrate strong efficacy, even in resistant cases, as well as non-covalent BTK inhibitors and BCL2 inhibitors.

His insights were shared at the 18th International Conference on Malignant Lymphoma in Lugano.

Latest scientific advancements in hematology highlighted in Hemostasis Today.